UiPath Inc.PATHNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-28.5%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-28.5%/yr
Annual compound
Percentile
P29
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20261.20%
202514.63%
202416.22%
20233.29%
2022151.69%
2021-16.13%
202095.85%
20190.00%